CASI News and Press, CASI Pharmaceuticals Inc. From 01/28/21

BioInvent International (BOVNF) and partner CASI Pharmaceuticals (CASI) announce positive interim results from the Phase I/IIa trial of novel anti-FcγRIIB antibody BI-1206 in combination with rituximab (anti-CD20 monoclonal antibody) in patients with indolent relapsed or refr...

Edesa Biotech (EDSA) +97% on regulatory nod for sub set of phase2/3 EB05 COVID-19 study.Koss Corporation (KOSS) +84%.Phunware (PHUN) +65%.Vertex Energy (VTNR) +52%.Myomo (MYO) +33% on JV to manufacture and sell the company’s products in China.AIkido Pharma (AIKI) +2...

Nasdaq & NYSE Penny Stocks To Watch This Week We always talk about following trends when it comes to penny stocks . It might be a niche like electric vehicles or an entire sector like biotech. On this note, the latter has been one of the hottest corners of the stock market today...

CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On BI-1206 For Relapsed Or Refractory Non-Hodgkin's Lymphoma PR Newswire ROCKVILLE, Md. and BEIJING , Jan. 21, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S....

CASI Pharmaceuticals, Inc. To Present At H.C. Wainwright Bioconnect Conference PR Newswire ROCKVILLE, Md., and BEIJING , Jan. 8, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and c...

Jacobio raised $174 million in a Hong Kong IPO to develop its portfolio of 12 novel drugs. WuXi Biologics will add more CDMO capacity by spending $183 million to acquire a Bayer facility in Germany. CASI Pharma announced its partnered CD19 CAR-T product was granted Breakthrough De...

Lizhi (LIZI) +29%.Ekso Bionics Holdings (EKSO) +25%.AgEagle Aerial Systems (UAVS) +22%.ENGlobal Corporation (ENG) +23%.Supernus Pharmaceuticals (SUPN) +23%.Scopus BioPharma (SCPS) +21%.Mogo (MOGO) +18%.Magnite (MGNI) +18%.Kopin Corporation (KOPN) +18%.Magna International (MGA) +18%.InMed Phar...

The Chinese Center for Drug Evaluation has granted Breakthrough Therapy Designation to CASI Pharmaceuticals' (CASI) partner Juventas Cell Therapy, for CNCT19, a CD19 CAR-T therapy for the treatment of adults with relapsed/refractory B-cell acute lymphoblastic leukemia.CASI has co-commercial r...

CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation - Second CAR-T 19 drug in global development (and first CAR-T 19 drug developed locally in China) to receive China Breakthrough Therapy Designation - PR Newswire ROCKVI...

Will These Penny Stocks Reach New Highs Before Next Year? Looking for penny stocks to buy can be easier said than done. One of the main reasons is that emotions can easily impact when and how you buy or sell. Simply put, it isn’t uncommon to see these cheap stocks race higher...